You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DACARBAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Dacarbazine

A generic version of DACARBAZINE was approved as dacarbazine by MEITHEAL on August 27th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DACARBAZINE?
  • What are the global sales for DACARBAZINE?
  • What is Average Wholesale Price for DACARBAZINE?
Drug patent expirations by year for DACARBAZINE
Drug Prices for DACARBAZINE

See drug prices for DACARBAZINE

Recent Clinical Trials for DACARBAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Diwakar DavarPhase 2
IDEAYA BiosciencesPhase 2/Phase 3
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 3

See all DACARBAZINE clinical trials

Pharmacology for DACARBAZINE
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for DACARBAZINE

US Patents and Regulatory Information for DACARBAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm DACARBAZINE dacarbazine INJECTABLE;INJECTION 070962-001 Aug 28, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira DACARBAZINE dacarbazine INJECTABLE;INJECTION 075940-001 Oct 18, 2001 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa DACARBAZINE dacarbazine INJECTABLE;INJECTION 075371-002 Aug 27, 1999 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.